Fund profile by ISIN IE00BM8R0N95
Global X Genomics & Biotechnology UCITS ETF
Research Global X Genomics & Biotechnology UCITS ETF by ISIN IE00BM8R0N95: TER 0.50%, domicile Ireland, and 1-year price performance +78.0%.
ISINIE00BM8R0N95
TER0.50%
DomicileIreland
Distribution policy—
Index—
Fund size52M
Holdings—
1-year price performance+78.0%
Exchange listings and tradability
| Ticker | Exchange | Currency | Country | Avg daily turnover | Avg daily shares |
|---|---|---|---|---|---|
| GNOG.L | LSE | GBP | Ireland | €299K | 33,109 |
| GN0M.DE | XETRADefault at German brokers | EUR | Ireland | €206K | 23,456 |
| GNOM.L | LSE | USD | Ireland | €109K | 12,035 |
| GNOM.MI | ETFP | EUR | Ireland | €80K | 9,061 |
| GNOM.SW | SW | CHF | Ireland | €5K | 612 |
Avg daily turnover is the 90-day average, converted to euros so venues in different currencies can be compared; avg daily shares is the same window in units. The most traded listing is shown first. This fund trades on a German exchange. As of 2026-08-28.
Largest holdings
The 9 largest holdings make up 42.18% of the fund. As of 2026-08-14.
| Holding | Symbol | Weight |
|---|---|---|
| Guardant Health Inc | GH | 6.37% |
| Illumina Inc | ILMN | 5.52% |
| Twist Bioscience Corp | TWST | 4.94% |
| 10x Genomics Inc Ordinary Shares - Class A | TXG | 4.93% |
| Natera Inc | NTRA | 4.52% |
| Bio-Techne Corp | TECH | 4.33% |
| Arrowhead Pharmaceuticals Inc | ARWR | 4.03% |
| Biomarin Pharmaceutical Inc | BMRN | 3.91% |
| Qiagen NV | QGEN | 3.64% |
Performance is the historical price return of the representative listing. Distributions are excluded and past performance is not a forecast.